Page last updated: 2024-10-16

carnitine and Acute-On-Chronic Liver Failure (ACLF)

carnitine has been researched along with Acute-On-Chronic Liver Failure (ACLF) in 1 studies

Research Excerpts

ExcerptRelevanceReference
"Treatment with simvastatin and rifaximin was associated with changes in 161 of 985 metabolites in comparison to treatment with placebo."3.11Treatment With Simvastatin and Rifaximin Restores the Plasma Metabolomic Profile in Patients With Decompensated Cirrhosis. ( Abraldes, JG; Alessandria, C; Beuers, U; Campion, D; Caraceni, P; Carol, M; Davis, MM; de Wit, K; Durand, F; Francoz, C; Ginès, P; Jiménez, C; Juanola, A; Kamath, PS; Kazankov, K; Lozano, JJ; Ma, AT; Mookerjee, RP; Morales-Ruiz, M; Napoleone, L; Piano, S; Pose, E; Sidorova, J; Solà, E; Tonon, M; Trebicka, J; Uschner, F; Vargas, V; Watson, H; Zaccherini, G, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Pose, E1
Solà, E1
Lozano, JJ1
Juanola, A1
Sidorova, J1
Zaccherini, G1
de Wit, K1
Uschner, F1
Tonon, M1
Kazankov, K1
Jiménez, C1
Campion, D1
Napoleone, L1
Ma, AT1
Carol, M1
Morales-Ruiz, M1
Alessandria, C1
Beuers, U1
Caraceni, P1
Francoz, C1
Durand, F1
Mookerjee, RP1
Trebicka, J1
Vargas, V1
Piano, S1
Watson, H1
Abraldes, JG1
Kamath, PS1
Davis, MM1
Ginès, P1

Trials

1 trial available for carnitine and Acute-On-Chronic Liver Failure (ACLF)

ArticleYear
Treatment With Simvastatin and Rifaximin Restores the Plasma Metabolomic Profile in Patients With Decompensated Cirrhosis.
    Hepatology communications, 2022, Volume: 6, Issue:5

    Topics: Acute-On-Chronic Liver Failure; Carnitine; Humans; Kynurenine; Liver Cirrhosis; Metabolomics; Rifaxi

2022